"Quantum technologies have long been pitched as a way to fundamentally change the way drugs are discovered; to start putting the theory to the test, researchers from pharmaceutical company GlaxoSmithKline (GSK) have been toying with top-notch quantum devices, comparing the methods put forward by IBM and D-Wave to get a better picture of what to expect from those leading the quantum race.
The conclusion? The method used by D-Wave, called quantum annealing, can already compete against classical computers and start addressing realistic problems; on the other hand, gate-based quantum computers, such as the one that IBM is building, remain short of enough qubits to run problems that are relevant to the real world." Read the article at ZDNet.